Author:
Swart Joost F.,Lindemans Caroline A.,van Royen Annet,Boelens Jaap J.,Prakken Berent J.,Wulffraat Nico
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference33 articles.
1. Rituximab for rheumatoid arthritis refractory to antitumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.;Cohen;Arthritis Rheum,2006
2. Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade.;Redlich;Arthritis Rheum,2003
3. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial.;Ruperto;Lancet,2008
4. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity.;de Kleer;Ann Rheum Dis,2004
5. Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy.;Flato;J Rheumatol,1998
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献